RÉSUMÉ
Mitochondrial Ca2+ ions are crucial regulators of bioenergetics and cell death pathways. Mitochondrial Ca2+ content and cytosolic Ca2+ homeostasis strictly depend on Ca2+ transporters. In recent decades, the major players responsible for mitochondrial Ca2+ uptake and release have been identified, except the mitochondrial Ca2+ /H+ exchanger (CHE). Originally identified as the mitochondrial K+ /H+ exchanger, LETM1 was also considered as a candidate for the mitochondrial CHE. Defining the mitochondrial interactome of LETM1, we identify TMBIM5/MICS1, the only mitochondrial member of the TMBIM family, and validate the physical interaction of TMBIM5 and LETM1. Cell-based and cell-free biochemical assays demonstrate the absence or greatly reduced Na+ -independent mitochondrial Ca2+ release in TMBIM5 knockout or pH-sensing site mutants, respectively, and pH-dependent Ca2+ transport by recombinant TMBIM5. Taken together, we demonstrate that TMBIM5, but not LETM1, is the long-sought mitochondrial CHE, involved in setting and regulating the mitochondrial proton gradient. This finding provides the final piece of the puzzle of mitochondrial Ca2+ transporters and opens the door to exploring its importance in health and disease, and to developing drugs modulating Ca2+ exchange.
Sujet(s)
Antiports , Protons , Antiports/génétiqueRÉSUMÉ
Infections induce complex host responses linked to antiviral defense, inflammation, and tissue damage and repair. We hypothesized that the liver, as a central metabolic hub, may orchestrate systemic metabolic changes during infection. We infected mice with chronic lymphocytic choriomeningitis virus (LCMV), performed RNA sequencing and proteomics of liver tissue, and integrated these data with serum metabolomics at different infection phases. Widespread reprogramming of liver metabolism occurred early after infection, correlating with type I interferon (IFN-I) responses. Viral infection induced metabolic alterations of the liver that depended on the interferon alpha/beta receptor (IFNAR1). Hepatocyte-intrinsic IFNAR1 repressed the transcription of metabolic genes, including Otc and Ass1, which encode urea cycle enzymes. This led to decreased arginine and increased ornithine concentrations in the circulation, resulting in suppressed virus-specific CD8+ T cell responses and ameliorated liver pathology. These findings establish IFN-I-induced modulation of hepatic metabolism and the urea cycle as an endogenous mechanism of immunoregulation. VIDEO ABSTRACT.
Sujet(s)
Lymphocytes T CD4+/immunologie , Lymphocytes T CD8+/immunologie , Interféron de type I/immunologie , Foie/métabolisme , Virus de la chorioméningite lymphocytaire/immunologie , Récepteur à l'interféron alpha-bêta/métabolisme , Animaux , Arginine/sang , Lignée cellulaire , Chlorocebus aethiops , Cricetinae , Femelle , Hépatocytes/métabolisme , Foie/immunologie , Foie/virologie , Chorioméningite lymphocytaire/immunologie , Mâle , Souris , Souris de lignée C57BL , Souris knockout , Ornithine/sang , Ornithine carbamoyltransferase/génétique , Transduction du signal/immunologie , Urée/métabolisme , Cellules VeroRÉSUMÉ
The histone acetyl reader bromodomain-containing protein 4 (BRD4) is an important regulator of chromatin structure and transcription, yet factors modulating its activity have remained elusive. Here we describe two complementary screens for genetic and physical interactors of BRD4, which converge on the folate pathway enzyme MTHFD1 (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1). We show that a fraction of MTHFD1 resides in the nucleus, where it is recruited to distinct genomic loci by direct interaction with BRD4. Inhibition of either BRD4 or MTHFD1 results in similar changes in nuclear metabolite composition and gene expression; pharmacological inhibitors of the two pathways synergize to impair cancer cell viability in vitro and in vivo. Our finding that MTHFD1 and other metabolic enzymes are chromatin associated suggests a direct role for nuclear metabolism in the control of gene expression.
Sujet(s)
Acide folique/métabolisme , Régulation de l'expression des gènes , Methylenetetrahydrofolate Dehydrogenase (NADP)/métabolisme , Antigènes mineurs d'histocompatibilité/métabolisme , Protéines nucléaires/métabolisme , Facteurs de transcription/métabolisme , Protéines du cycle cellulaire , Lignée cellulaire tumorale , Noyau de la cellule/métabolisme , Chromatine/génétique , Techniques de knock-out de gènes , Humains , Mutation perte de fonction , Liaison aux protéines , Cartographie d'interactions entre protéines , Cartes d'interactions protéiques , Transport des protéines , Transduction du signal , Transcription génétiqueRÉSUMÉ
The marsupial Tasmanian devil (Sarcophilus harrisii) faces extinction due to transmissible devil facial tumor disease (DFTD). To unveil the molecular underpinnings of this transmissible cancer, we combined pharmacological screens with an integrated systems-biology characterization. Sensitivity to inhibitors of ERBB tyrosine kinases correlated with their overexpression. Proteomic and DNA methylation analyses revealed tumor-specific signatures linked to the evolutionary conserved oncogenic STAT3. ERBB inhibition blocked phosphorylation of STAT3 and arrested cancer cells. Pharmacological blockade of ERBB or STAT3 prevented tumor growth in xenograft models and restored MHC class I expression. This link between the hyperactive ERBB-STAT3 axis and major histocompatibility complex class I-mediated tumor immunosurveillance provides mechanistic insights into horizontal transmissibility and puts forward a dual chemo-immunotherapeutic strategy to save Tasmanian devils from DFTD. VIDEO ABSTRACT.
Sujet(s)
Récepteurs ErbB/métabolisme , Tumeurs de la face/traitement médicamenteux , Tumeurs de la face/médecine vétérinaire , Protéomique/méthodes , Facteur de transcription STAT-3/métabolisme , Bibliothèques de petites molécules/administration et posologie , Animaux , Méthylation de l'ADN , Tests de criblage d'agents antitumoraux , Tumeurs de la face/métabolisme , Régulation de l'expression des gènes tumoraux/effets des médicaments et des substances chimiques , Antigènes d'histocompatibilité de classe I/métabolisme , Marsupialia , Souris , Phosphorylation , Transduction du signal , Bibliothèques de petites molécules/pharmacologie , Tests d'activité antitumorale sur modèle de xénogreffeRÉSUMÉ
DExD/H box RNA helicases, such as the RIG-I-like receptors (RLR), are important components of the innate immune system. Here we demonstrate a pivotal and sex-specific role for the heterosomal isoforms of the DEAD box RNA helicase DDX3 in the immune system. Mice lacking DDX3X during hematopoiesis showed an altered leukocyte composition in bone marrow and spleen and a striking inability to combat infection with Listeria monocytogenes. Alterations in innate immune responses resulted from decreased effector cell availability and function as well as a sex-dependent impairment of cytokine synthesis. Thus, our data provide further in vivo evidence for an essential contribution of a non-RLR DExD/H RNA helicase to innate immunity and suggest it may contribute to sex-related differences in resistance to microbes and resilience to inflammatory disease.
Sujet(s)
Infections à Listeria/immunologie , RNA helicases/immunologie , Animaux , DEAD-box RNA helicases/métabolisme , Résistance à la maladie/immunologie , Femelle , Fibroblastes/immunologie , Fibroblastes/anatomopathologie , Cellules HEK293 , Hématopoïèse/immunologie , Humains , Immunité innée , Cellules tueuses naturelles/immunologie , Listeria monocytogenes/immunologie , Infections à Listeria/anatomopathologie , Lymphocytes/immunologie , Mâle , Souris , Souris knockout , Facteur de transcription NF-kappa B/immunologie , RNA helicases/déficit , RNA helicases/génétique , Facteurs sexuels , Transduction du signalRÉSUMÉ
MLL-fusions represent a large group of leukemia drivers, whose diversity originates from the vast molecular heterogeneity of C-terminal fusion partners of MLL. While studies of selected MLL-fusions have revealed critical molecular pathways, unifying mechanisms across all MLL-fusions remain poorly understood. We present the first comprehensive survey of protein-protein interactions of seven distantly related MLL-fusion proteins. Functional investigation of 128 conserved MLL-fusion-interactors identifies a specific role for the lysine methyltransferase SETD2 in MLL-leukemia. SETD2 loss causes growth arrest and differentiation of AML cells, and leads to increased DNA damage. In addition to its role in H3K36 tri-methylation, SETD2 is required to maintain high H3K79 di-methylation and MLL-AF9-binding to critical target genes, such as Hoxa9. SETD2 loss synergizes with pharmacologic inhibition of the H3K79 methyltransferase DOT1L to induce DNA damage, growth arrest, differentiation, and apoptosis. These results uncover a dependency for SETD2 during MLL-leukemogenesis, revealing a novel actionable vulnerability in this disease.
Sujet(s)
Histone-lysine N-methyltransferase/métabolisme , Leucémies/métabolisme , Protéine de la leucémie myéloïde-lymphoïde/métabolisme , Protéines de fusion oncogènes/métabolisme , Motifs d'acides aminés , Différenciation cellulaire , Lignée cellulaire tumorale , Altération de l'ADN , Histone-lysine N-methyltransferase/composition chimique , Histone-lysine N-methyltransferase/génétique , Humains , Leucémies/génétique , Leucémies/physiopathologie , Méthylation , Methyltransferases/génétique , Methyltransferases/métabolisme , Protéine de la leucémie myéloïde-lymphoïde/composition chimique , Protéine de la leucémie myéloïde-lymphoïde/génétique , Protéines nucléaires/génétique , Protéines nucléaires/métabolisme , Protéines de fusion oncogènes/génétique , Liaison aux protéinesRÉSUMÉ
Lymphatic endothelial cells (LECs) release extracellular chemokines to guide the migration of dendritic cells. In this study, we report that LECs also release basolateral exosome-rich endothelial vesicles (EEVs) that are secreted in greater numbers in the presence of inflammatory cytokines and accumulate in the perivascular stroma of small lymphatic vessels in human chronic inflammatory diseases. Proteomic analyses of EEV fractions identified >1,700 cargo proteins and revealed a dominant motility-promoting protein signature. In vitro and ex vivo EEV fractions augmented cellular protrusion formation in a CX3CL1/fractalkine-dependent fashion and enhanced the directional migratory response of human dendritic cells along guidance cues. We conclude that perilymphatic LEC exosomes enhance exploratory behavior and thus promote directional migration of CX3CR1-expressing cells in complex tissue environments.
Sujet(s)
Mouvement cellulaire , Cellules dendritiques/cytologie , Cellules dendritiques/métabolisme , Exosomes/métabolisme , Vaisseaux lymphatiques/métabolisme , Animaux , Lignée cellulaire tumorale , Prolongements cytoplasmiques/métabolisme , Microenvironnement cellulaire , Chimiokine CX3CL1/métabolisme , Collagène/métabolisme , Signaux , Cellules endothéliales/métabolisme , Cellules endothéliales/ultrastructure , Exosomes/ultrastructure , Humains , Inflammation/anatomopathologie , Rein/métabolisme , Rein/anatomopathologie , Mâle , Souris , Tumeurs de la prostate/métabolisme , Tumeurs de la prostate/anatomopathologie , Protéomique , Récepteurs couplés aux protéines G/métabolisme , Transduction du signal , Facteur de nécrose tumorale alpha/métabolismeRÉSUMÉ
Specific granule deficiency (SGD) is a rare disorder characterized by abnormal neutrophils evidenced by reduced granules, absence of granule proteins, and atypical bilobed nuclei. Mutations in CCAAT/enhancer-binding protein-ε (CEBPE) are one molecular etiology of the disease. Although C/EBPε has been studied extensively, the impact of CEBPE mutations on neutrophil biology remains elusive. Here, we identified two SGD patients bearing a previously described heterozygous mutation (p.Val218Ala) in CEBPE. We took this rare opportunity to characterize SGD neutrophils in terms of granule distribution and protein content. Granules of patient neutrophils were clustered and polarized, suggesting that not only absence of specific granules but also defects affecting other granules contribute to the phenotype. Our analysis showed that remaining granules displayed mixed protein content and lacked several glycoepitopes. To further elucidate the impact of mutant CEBPE, we performed detailed proteomic analysis of SGD neutrophils. Beside an absence of several granule proteins in patient cells, we observed increased expression of members of the linker of nucleoskeleton and cytoskeleton complex (nesprin-2, vimentin, and lamin-B2), which control nuclear shape. This suggests that absence of these proteins in healthy individuals might be responsible for segmented shapes of neutrophilic nuclei. We further show that the heterozygous mutation p.Val218Ala in CEBPE causes SGD through prevention of nuclear localization of the protein product. In conclusion, we uncover that absence of nuclear C/EBPε impacts on spatiotemporal expression and subsequent distribution of several granule proteins and further on expression of proteins controlling nuclear shape.
Sujet(s)
Protéines liant les séquences stimulatrices de type CCAAT/génétique , Lactoferrine/déficit , Troubles leucocytaires/étiologie , Troubles leucocytaires/métabolisme , Mutation , Granulocytes neutrophiles/métabolisme , Protéome , Adulte , Marqueurs biologiques , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Granulations cytoplasmiques/immunologie , Granulations cytoplasmiques/métabolisme , Épitopes/immunologie , Glycoprotéines/immunologie , Glycoprotéines/métabolisme , Humains , Lactoferrine/métabolisme , Glycoprotéines membranaires/immunologie , Glycoprotéines membranaires/métabolisme , Adulte d'âge moyen , Granulocytes neutrophiles/immunologie , Protéomique/méthodesRÉSUMÉ
Chromosome-centric Human Proteome Project aims at identifying and characterizing protein products encoded from all human protein-coding genes. As of early 2017, 19 837 protein-coding genes have been annotated in the neXtProt database including 2691 missing proteins that have never been identified by mass spectrometry. Missing proteins may be low abundant in many cell types or expressed only in a few cell types in human body such as sperms in testis. In this study, we performed expression proteomics of two near-haploid cell types such as HAP1 and KBM-7 to hunt for missing proteins. Proteomes from the two haploid cell lines were analyzed on an LTQ Orbitrap Velos, producing a total of 200 raw mass spectrometry files. After applying 1% false discovery rates at both levels of peptide-spectrum matches and proteins, more than 10 000 proteins were identified from HAP1 and KBM-7, resulting in the identification of nine missing proteins. Next, unmatched spectra were searched against protein databases translated in three frames from noncoding RNAs derived from RNA-Seq data, resulting in six novel protein-coding regions after careful manual inspection. This study demonstrates that expression proteomics coupled to proteogenomic analysis can be employed to identify many annotated and unannotated missing proteins.
Sujet(s)
Haploïdie , Protéogénomique/méthodes , Protéome/génétique , Transcriptome , Séquence d'acides aminés , Lignée cellulaire , Humains , Protéome/analyse , ARN non traduit/génétique , Analyse de séquence d'ARN/méthodes , Spectrométrie de masse en tandem/méthodesRÉSUMÉ
Protein degradation is an emerging therapeutic strategy with a unique molecular pharmacology that enables the disruption of all functions associated with a target. This is particularly relevant for proteins depending on molecular scaffolding, such as transcription factors or receptor tyrosine kinases (RTKs). To address tractability of multiple RTKs for chemical degradation by the E3 ligase CUL4-RBX1-DDB1-CRBN (CRL4CRBN), we synthesized a series of phthalimide degraders based on the promiscuous kinase inhibitors sunitinib and PHA665752. While both series failed to induce degradation of their consensus targets, individual molecules displayed pronounced efficacy in leukemia cell lines. Orthogonal target identification supported by molecular docking led us to identify the translation termination factor G1 to S phase transition 1 (GSPT1) as a converging off-target, resulting from inadvertent E3 ligase modulation. This research highlights the importance of monitoring degradation events that are independent of the respective targeting ligand as a unique feature of small-molecule degraders.
Sujet(s)
Terminaison de la traduction , Facteurs terminaison chaîne peptidique , Protéolyse , Lignée cellulaire tumorale , Humains , Simulation de docking moléculaire , Phtalimides/composition chimique , Inhibiteurs de protéines kinases/composition chimique , Ubiquitin-protein ligases/métabolismeRÉSUMÉ
Cardiovascular disease (CVD) is the leading cause of increased mortality in patients with CKD and is further aggravated by peritoneal dialysis (PD). Children are devoid of preexisting CVD and provide unique insight into specific uremia- and PD-induced pathomechanisms of CVD. We obtained peritoneal specimens from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with established PD (PD group), and age-matched nonuremic controls (n=6/group). We microdissected omental arterioles from tissue layers not directly exposed to PD fluid and used adjacent sections of four arterioles per patient for transcriptomic and proteomic analyses. Findings were validated in omental and parietal arterioles from independent pediatric control (n=5), CKD5 (n=15), and PD (n=15) cohorts. Transcriptomic analysis revealed differential gene expression in control versus CKD5 arterioles and in CKD5 versus PD arterioles. Gene ontology analyses revealed activation of metabolic processes in CKD5 arterioles and of inflammatory, immunologic, and stress-response cascades in PD arterioles. PD arterioles exhibited particular upregulation of the complement system and respective regulatory pathways, with concordant findings at the proteomic level. In the validation cohorts, PD specimens had the highest abundance of omental and parietal arteriolar C1q, C3d, terminal complement complex, and phosphorylated SMAD2/3, a downstream effector of TGF-ß Furthermore, in the PD parietal arterioles, C1q and terminal complement complex abundance correlated with the level of dialytic glucose exposure, abundance of phosphorylated SMAD2/3, and degree of vasculopathy. We conclude that PD fluids activate arteriolar complement and TGF-ß signaling, which quantitatively correlate with the severity of arteriolar vasculopathy.
Sujet(s)
Artérioles/métabolisme , Activation du complément , Protéines du système du complément/métabolisme , Défaillance rénale chronique/thérapie , Dialyse péritonéale/effets indésirables , Maladies vasculaires/métabolisme , Adolescent , Études cas-témoins , Enfant , Enfant d'âge préscolaire , Complément C1q/métabolisme , Complément C3d/métabolisme , Complexe d'attaque membranaire du complément/métabolisme , Femelle , Gene Ontology , Humains , Nourrisson , Nouveau-né , Défaillance rénale chronique/complications , Mâle , Omentum/vascularisation , Phosphorylation , Protéome , Indice de gravité de la maladie , Transduction du signal , Protéine Smad2/métabolisme , Protéine Smad-3/métabolisme , Transcriptome , Facteur de croissance transformant bêta/métabolisme , Urémie/étiologie , Maladies vasculaires/étiologie , Facteur de croissance endothéliale vasculaire de type A/métabolismeRÉSUMÉ
Peritoneal dialysis (PD) is a modality of renal replacement therapy in which the high volumes of available PD effluent (PDE) represents a rich source of biomarkers for monitoring disease and therapy. Although this information could help guide the management of PD patients, little is known about the potential of PDE to define pathomechanism-associated molecular signatures in PD.We therefore subjected PDE to a high-performance multiplex proteomic analysis after depletion of highly-abundant plasma proteins and enrichment of low-abundance proteins. A combination of label-free and isobaric labeling strategies was applied to PDE samples from PD patients (n = 20) treated in an open-label, randomized, two-period, cross-over clinical trial with standard PD fluid or with a novel PD fluid supplemented with alanyl-glutamine (AlaGln).With this workflow we identified 2506 unique proteins in the PDE proteome, greatly increasing coverage beyond the 171 previously-reported proteins. The proteins identified range from high abundance plasma proteins to low abundance cellular proteins, and are linked to larger numbers of biological processes and pathways, some of which are novel for PDE. Interestingly, proteins linked to membrane remodeling and fibrosis are overrepresented in PDE compared with plasma, whereas the proteins underrepresented in PDE suggest decreases in host defense, immune-competence and response to stress. Treatment with AlaGln-supplemented PD fluid is associated with reduced activity of membrane injury-associated mechanisms and with restoration of biological processes involved in stress responses and host defense.Our study represents the first application of the PDE proteome in a randomized controlled prospective clinical trial of PD. This novel proteomic workflow allowed detection of low abundance biomarkers to define pathomechanism-associated molecular signatures in PD and their alterations by a novel therapeutic intervention.
Sujet(s)
Dipeptides/pharmacologie , Dialyse péritonéale , Protéome , Protéines du sang/métabolisme , Études croisées , Femelle , Humains , MâleRÉSUMÉ
RNA-dependent RNA polymerases (RdRps) play a key role in the life cycle of RNA viruses and impact their immunobiology. The arenavirus lymphocytic choriomeningitis virus (LCMV) strain Clone 13 provides a benchmark model for studying chronic infection. A major genetic determinant for its ability to persist maps to a single amino acid exchange in the viral L protein, which exhibits RdRp activity, yet its functional consequences remain elusive. To unravel the L protein interactions with the host proteome, we engineered infectious L protein-tagged LCMV virions by reverse genetics. A subsequent mass-spectrometric analysis of L protein pulldowns from infected human cells revealed a comprehensive network of interacting host proteins. The obtained LCMV L protein interactome was bioinformatically integrated with known host protein interactors of RdRps from other RNA viruses, emphasizing interconnected modules of human proteins. Functional characterization of selected interactors highlighted proviral (DDX3X) as well as antiviral (NKRF, TRIM21) host factors. To corroborate these findings, we infected Trim21-/- mice with LCMV and found impaired virus control in chronic infection. These results provide insights into the complex interactions of the arenavirus LCMV and other viral RdRps with the host proteome and contribute to a better molecular understanding of how chronic viruses interact with their host.
Sujet(s)
DEAD-box RNA helicases/métabolisme , Virus de la chorioméningite lymphocytaire/enzymologie , Modèles moléculaires , RNA replicase/métabolisme , Protéines de répression/métabolisme , Ribonucléoprotéines/métabolisme , Protéines virales/métabolisme , Animaux , Systèmes CRISPR-Cas , Biologie informatique , Croisements génétiques , DEAD-box RNA helicases/composition chimique , Femelle , Cellules HEK293 , Humains , Immunoprécipitation , Chorioméningite lymphocytaire/métabolisme , Chorioméningite lymphocytaire/médecine vétérinaire , Mâle , Souris de lignée C57BL , Souris knockout , Motifs et domaines d'intéraction protéique , RNA replicase/composition chimique , RNA replicase/génétique , Protéines de fusion recombinantes/composition chimique , Protéines de fusion recombinantes/métabolisme , Protéines de répression/composition chimique , Ribonucléoprotéines/composition chimique , Ribonucléoprotéines/génétique , Organismes exempts d'organismes pathogènes spécifiques , Protéines virales/composition chimique , Protéines virales/génétiqueRÉSUMÉ
Signaling from lysosomes controls cellular clearance and energy metabolism. Lysosomal malfunction has been implicated in several pathologies, including neurodegeneration, cancer, infection, immunodeficiency, and obesity. Interestingly, many functions are dependent on the organelle position. Lysosomal motility requires the integration of extracellular and intracellular signals that converge on a competition between motor proteins that ultimately control lysosomal movement on microtubules. Here, we identify a novel upstream control mechanism of Arl8b-dependent lysosomal movement toward the periphery of the cell. We show that the C-terminal domain of lyspersin, a subunit of BLOC-1-related complex (BORC), is essential and sufficient for BORC-dependent recruitment of Arl8b to lysosomes. In addition, we establish lyspersin as the linker between BORC and late endosomal/lysosomal adaptor and mitogen activated protein kinase and mechanistic target of rapamycin activator (LAMTOR) complexes and show that epidermal growth factor stimulation decreases LAMTOR/BORC association, thereby promoting BORC- and Arl8b-dependent lysosomal centrifugal transport.
Sujet(s)
Facteurs d'ADP-ribosylation/métabolisme , Protéines de transport/métabolisme , Endosomes/métabolisme , Lysosomes/métabolisme , Complexes multiprotéiques/métabolisme , Protéines de tissu nerveux/métabolisme , Facteurs d'ADP-ribosylation/génétique , Protéines de transport/génétique , Endosomes/effets des médicaments et des substances chimiques , Endosomes/ultrastructure , Facteur de croissance épidermique/pharmacologie , Régulation de l'expression des gènes , Cellules HEK293 , Cellules HeLa , Humains , Protéines et peptides de signalisation intracellulaire , Lysosomes/effets des médicaments et des substances chimiques , Lysosomes/ultrastructure , Microtubules/effets des médicaments et des substances chimiques , Microtubules/métabolisme , Microtubules/ultrastructure , Mouvement , Complexes multiprotéiques/génétique , Protéines de tissu nerveux/génétique , Isoformes de protéines/génétique , Isoformes de protéines/métabolisme , Transport des protéines , Transduction du signalRÉSUMÉ
In melanoma, therapies with inhibitors to oncogenic BRAFV600E are highly effective but responses are often short-lived due to the emergence of drug-resistant tumor subpopulations. We describe here a mechanism of acquired drug resistance through the tumor microenvironment, which is mediated by human tumor-associated B cells. Human melanoma cells constitutively produce the growth factor FGF-2, which activates tumor-infiltrating B cells to produce the growth factor IGF-1. B-cell-derived IGF-1 is critical for resistance of melanomas to BRAF and MEK inhibitors due to emergence of heterogeneous subpopulations and activation of FGFR-3. Consistently, resistance of melanomas to BRAF and/or MEK inhibitors is associated with increased CD20 and IGF-1 transcript levels in tumors and IGF-1 expression in tumor-associated B cells. Furthermore, first clinical data from a pilot trial in therapy-resistant metastatic melanoma patients show anti-tumor activity through B-cell depletion by anti-CD20 antibody. Our findings establish a mechanism of acquired therapy resistance through tumor-associated B cells with important clinical implications.Resistance to BRAFV600E inhibitors often occurs in melanoma patients. Here, the authors describe a potential mechanism of acquired drug resistance mediated by tumor-associated B cells-derived IGF-1.
Sujet(s)
Antinéoplasiques/usage thérapeutique , Lymphocytes B/métabolisme , Résistance aux médicaments antinéoplasiques , Facteur de croissance IGF-I/métabolisme , Lymphocytes TIL/métabolisme , Mélanome/traitement médicamenteux , Inhibiteurs de protéines kinases/usage thérapeutique , Tumeurs cutanées/traitement médicamenteux , Anticorps monoclonaux/usage thérapeutique , Anticorps monoclonaux humanisés , Survie cellulaire , Cisplatine/usage thérapeutique , Facteur de croissance fibroblastique de type 2/métabolisme , Humains , Techniques in vitro , Mélanome/génétique , Paclitaxel/usage thérapeutique , Projets pilotes , Protéines proto-oncogènes B-raf/génétique , Récepteur de type 3 des facteurs de croissance fibroblastique/métabolisme , Tumeurs cutanées/génétique , Microenvironnement tumoralRÉSUMÉ
Approved drugs are invaluable tools to study biochemical pathways, and further characterization of these compounds may lead to repurposing of single drugs or combinations. Here we describe a collection of 308 small molecules representing the diversity of structures and molecular targets of all FDA-approved chemical entities. The CeMM Library of Unique Drugs (CLOUD) covers prodrugs and active forms at pharmacologically relevant concentrations and is ideally suited for combinatorial studies. We screened pairwise combinations of CLOUD drugs for impairment of cancer cell viability and discovered a synergistic interaction between flutamide and phenprocoumon (PPC). The combination of these drugs modulates the stability of the androgen receptor (AR) and resensitizes AR-mutant prostate cancer cells to flutamide. Mechanistically, we show that the AR is a substrate for γ-carboxylation, a post-translational modification inhibited by PPC. Collectively, our data suggest that PPC could be repurposed to tackle resistance to antiandrogens in prostate cancer patients.
Sujet(s)
Évaluation préclinique de médicament , Récepteurs aux androgènes/métabolisme , Bibliothèques de petites molécules/analyse , Bibliothèques de petites molécules/pharmacologie , Lignée cellulaire tumorale , Survie cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Flutamide/pharmacologie , Humains , Mâle , Structure moléculaire , Phenprocoumone/pharmacologie , Tumeurs de la prostate/traitement médicamenteux , Tumeurs de la prostate/métabolisme , Tumeurs de la prostate/anatomopathologie , Bibliothèques de petites molécules/composition chimique , Relation structure-activitéRÉSUMÉ
Mice lacking Cdk6 kinase activity suffer from mild anemia accompanied by elevated numbers of Ter119+ cells in the bone marrow. The animals show hardly any alterations in erythroid development, indicating that Cdk6 is not required for proliferation and maturation of erythroid cells. There is also no difference in stress erythropoiesis following hemolysis in vivo However, Cdk6-/- erythrocytes have a shortened lifespan and are more sensitive to mechanical stress in vitro, suggesting differences in cytoskeletal architecture. Erythroblasts contain both Cdk4 and Cdk6, while mature erythrocytes apparently lack Cdk4 and their Cdk6 is partly associated with the cytoskeleton. We used mass spectrometry to show that Cdk6 interacts with a number of proteins involved in cytoskeleton organization. Cdk6-/- erythroblasts show impaired F-actin formation and lower levels of gelsolin, which interacts with Cdk6. We also found that Cdk6 regulates the transcription of a panel of genes involved in actin (de-)polymerization. Cdk6-deficient cells are sensitive to drugs that interfere with the cytoskeleton, suggesting that our findings are relevant to the treatment of patients with anemia - and may be relevant to cancer patients treated with the new generation of CDK6 inhibitors.
Sujet(s)
Kinase-6 cycline-dépendante/physiologie , Cytosquelette/ultrastructure , Cellules érythroïdes/ultrastructure , Cytosquelette d'actine , Actines/métabolisme , Anémie , Animaux , Gelsoline/métabolisme , Régulation de l'expression des gènes , Spectrométrie de masse , Souris , Souris de lignée C57BLRÉSUMÉ
Mass spectrometric-based proteomics is a powerful tool to analyze post-translationally modified proteins. Carbonylation modifications that result from oxidative lipid breakdown are a class of post-translational modifications that are poorly characterized with respect to protein targets and function. This is partly due to the lack of dedicated mass spectrometry-based technologies to facilitate the analysis of these modifications. Here, we present a comprehensive approach to identify malondialdehyde-modified proteins and peptides. Malondialdehyde is among the most abundant of the lipid peroxidation products; and malondialdehyde-derived adducts on proteins have been implicated in cardiovascular diseases, neurodegenerative disorders, and other clinical conditions. Our integrated approach targets three levels of the overall proteomic workflow: (i) sample preparation, by employing a targeted enrichment strategy; (ii) high-performance liquid chromatography, by using a gradient optimized for the separation of the modified peptides; and (iii) tandem mass spectrometry, by improving the spectral quality of very low-abundance peptides. By applying the optimized procedure to a whole cell lysate spiked with a low amount of malondialdehyde-modified proteins, we were able to identify up to 350 different modified peptides and localize the modification to a specific lysine residue. This methodology allows the comprehensive analysis of malondialdehyde-modified proteins.
Sujet(s)
Malonaldéhyde/analyse , Peptides/composition chimique , Protéines/composition chimique , Spectrométrie de masse , Structure moléculaireRÉSUMÉ
Improvements in survival for Ewing sarcoma pediatric and adolescent patients have been modest over the past 20 years. Combinations of anticancer agents endure as an option to overcome resistance to single treatments caused by compensatory pathways. Moreover, combinations are thought to lessen any associated adverse side effects through reduced dosing, which is particularly important in childhood tumors. Using a parallel phenotypic combinatorial screening approach of cells derived from three pediatric tumor types, we identified Ewing sarcoma-specific interactions of a diverse set of targeted agents including approved drugs. We were able to retrieve highly synergistic drug combinations specific for Ewing sarcoma and identified signaling processes important for Ewing sarcoma cell proliferation determined by EWS-FLI1 We generated a molecular target profile of PKC412, a multikinase inhibitor with strong synergistic propensity in Ewing sarcoma, revealing its targets in critical Ewing sarcoma signaling routes. Using a multilevel experimental approach including quantitative phosphoproteomics, we analyzed the molecular rationale behind the disease-specific synergistic effect of simultaneous application of PKC412 and IGF1R inhibitors. The mechanism of the drug synergy between these inhibitors is different from the sum of the mechanisms of the single agents. The combination effectively inhibited pathway crosstalk and averted feedback loop repression, in EWS-FLI1-dependent manner. Mol Cancer Ther; 16(1); 88-101. ©2016 AACR.
Sujet(s)
Antinéoplasiques/pharmacologie , Découverte de médicament , Tests de criblage d'agents antitumoraux , Thérapie moléculaire ciblée , Animaux , Antigènes CD , Lignée cellulaire tumorale , Biologie informatique/méthodes , Modèles animaux de maladie humaine , Évaluation préclinique de médicament , Interactions médicamenteuses , Humains , Protéines de fusion oncogènes/antagonistes et inhibiteurs , Phosphorylation , Inhibiteurs de protéines kinases/pharmacologie , Protéomique/méthodes , Protéine proto-oncogène c-fli-1/antagonistes et inhibiteurs , Protéine EWS de liaison à l'ARN/antagonistes et inhibiteurs , Récepteur IGF de type 1 , Récepteur à l'insuline/antagonistes et inhibiteurs , Récepteurs des somatomédines/antagonistes et inhibiteurs , Sarcome d'Ewing/traitement médicamenteux , Sarcome d'Ewing/génétique , Sarcome d'Ewing/métabolisme , Sarcome d'Ewing/anatomopathologie , Transduction du signal/effets des médicaments et des substances chimiques , Staurosporine/analogues et dérivés , Staurosporine/pharmacologie , Tests d'activité antitumorale sur modèle de xénogreffeRÉSUMÉ
Diet-related health issues such as nonalcoholic fatty liver disease and cardiovascular disorders are known to have a major inflammatory component. However, the exact pathways linking diet-induced changes (e.g., hyperlipidemia) and the ensuing inflammation have remained elusive so far. We identified biological processes related to innate immunity and oxidative stress as prime response pathways in livers of low-density lipoprotein receptor-deficient mice on a Western-type diet using RNA sequencing and in silico functional analyses of transcriptome data. The observed changes were independent of the presence of microbiota and thus indicative of a role for sterile triggers. We further show that malondialdehyde (MDA) epitopes, products of lipid peroxidation and markers for enhanced oxidative stress, are detectable in hepatic inflammation predominantly on dying cells and stimulate cytokine secretion as well as leukocyte recruitment in vitro and in vivo. MDA-induced cytokine secretion in vitro was dependent on the presence of the scavenger receptors CD36 and MSR1. Moreover, in vivo neutralization of endogenously generated MDA epitopes by intravenous injection of a specific MDA antibody results in decreased hepatic inflammation in low-density lipoprotein receptor-deficient mice on a Western-type diet. CONCLUSION: Accumulation of MDA epitopes plays a major role during diet-induced hepatic inflammation and can be ameliorated by administration of an anti-MDA antibody. (Hepatology 2017;65:1181-1195).